Product Information
RECLIPSEN 28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1346 per EA under NDC 00093330416. Its NADAC has been published 478 times since May 3, 2017.
The High Outlier badge above means this manufacturer's average price in the Desogestrel and Ethinyl Estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093330416
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075256On Market Since
1/1/2017
Price Statistics
The NADAC for RECLIPSEN 28 DAY TABLET has been published 478 times since May 3, 2017, and over the history we have for it it has declined 67.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1346 per EA |
|---|---|
| All-time high | $0.4371 (Sep 13, 2017) |
| All-time low | $0.1111 (Nov 20, 2024) |
| 52-week high | $0.1544 |
| 52-week low | $0.1299 |
| Median price | $0.2077 |
| Average price | $0.2372 |
| Largest weekly change | -31.0% (Sep 23, 2020) |
| Weeks tracked | 478 |
| Tracking since | May 3, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RECLIPSEN 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RECLIPSEN 28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1346 per EA (NDC 00093330416), effective Jun 24, 2026.
How has the price of RECLIPSEN 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for RECLIPSEN 28 DAY TABLET has declined 67.9%. It has been tracked across 478 weekly CMS publications since May 3, 2017.
What are the highest and lowest recorded NADAC prices for RECLIPSEN 28 DAY TABLET?
Since May 3, 2017, the NADAC for RECLIPSEN 28 DAY TABLET has ranged from a low of $0.1111 (Nov 20, 2024) to a high of $0.4371 (Sep 13, 2017), with a median of $0.2077 per EA.
Are there cheaper alternatives to RECLIPSEN 28 DAY TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as RECLIPSEN 28 DAY TABLET, but none are currently priced below it.
Who manufactures RECLIPSEN 28 DAY TABLET?
RECLIPSEN 28 DAY TABLET (NDC 00093330416) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification